Cargando…
Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
Kawasaki disease (KD), an autoinflammatory disease primarily affecting young children, characterized by consisting of acute systemic vasculitis and coronary artery involvement in severe cases. Intravenous immunoglobulin gamma (IVIG) combined with aspirin therapy is the first-line regimen for the pre...
Autores principales: | Chen, Jiaying, Liao, Jian, Xiang, Lupeng, Zhang, Shilong, Yan, Yajing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626541/ https://www.ncbi.nlm.nih.gov/pubmed/37936712 http://dx.doi.org/10.3389/fimmu.2023.1237670 |
Ejemplares similares
-
HLAII peptide presentation of infliximab increases when complexed with TNF
por: Casasola-LaMacchia, Andrea, et al.
Publicado: (2022) -
Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
por: Ye, Chenglin, et al.
Publicado: (2022) -
Platelet-derived microRNA-223 attenuates TNF-α induced monocytes adhesion to arterial endothelium by targeting ICAM-1 in Kawasaki disease
por: Guo, Manli, et al.
Publicado: (2022) -
Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014) -
Humanization and Characterization of an Anti-Human TNF-α Murine Monoclonal Antibody
por: Chiu, Wei-Chun, et al.
Publicado: (2011)